United States · FDA National Drug Code directory
Risedronate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60723-041_460cdef1-681b-7ae4-e063-6294a90a1d55
- Product NDC
- 60723-041
- Form
- TABLET, FILM COATED
- Composition / generic term
- Risedronate Sodium
- Labeler
- Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190401
- Source listing expiry
- 20261231
Source-listed ingredients
- RISEDRONATE SODIUM HEMI-PENTAHYDRATE — 35 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (60723-041-04) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01) · 60723-041-04
- 3 BLISTER PACK in 1 CARTON (60723-041-12) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01) · 60723-041-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →